Inventor · disambiguated record
Susan Greenfield
Also filed as: GREENFIELD SUSAN · GREENFIELD SUSAN A · GREENFIELD SUSAN ADELE
16 granted patents·11 pending applications·206 citations·filing 1991–2022
93Inventor score
Top patents by PatentIndex Score
27 records- 0186US10053677B2Neurodegenerative disordersNEURO BIO LTD·Filed 2014·Granted Aug 21, 2018·7 cites·6 claims
- 0283US10954306B2Antibody that recognises the T14 peptide of AChENEURO BIO LTD·Filed 2016·Granted Mar 23, 2021·3 cites·6 claims
- 0381US11091747B2Neurodegenerative disordersNEURO BIO LTD·Filed 2018·Granted Aug 17, 2021·2 cites·17 claims
- 0477US8977986B2Control panel and ring interface for computing systemsHERZ WILLIAM·Filed 2011·Granted Mar 10, 2015·8 cites·12 claims
- 0577US5215985AMethod for treating ischemic insult to neurons employing an ATP-sensitive potassium channel blockerSQUIBB & SONS INC·Filed 1992·Granted Jun 1, 1993·45 cites·6 claims
- 0676US10729749B2Neurodegenerative disordersNEURO BIO LTD·Filed 2015·Granted Aug 4, 2020·3 cites·10 claims
- 0776US5677344AMethod for treating Parkinson's disease employing an ATP-sensitive potassium channel blockerSQUIBB & SONS INC·Filed 1993·Granted Oct 14, 1997·55 cites·15 claims
- 0875US12139729B2Neurodegenerative disordersNEURO BIO LTD·Filed 2021·Granted Nov 12, 2024·0 cites·1 claims
- 0972US5451580AMethod for treating insult to neurons prone to Parkinson's degeneration employing an ATP-sensitive potassium channel blockerSQUIBB & SONS INC·Filed 1993·Granted Sep 19, 1995·33 cites·7 claims
- 1069US10441638B2Cyclic acetylcholinesterase c-terminal peptide in the treatment or prevention of cancer or metastasisNEURO BIO LTD·Filed 2015·Granted Oct 15, 2019·1 cites·3 claims
- 1164US5281599AMethod for treating ischemic oranoxic insult to neurons employing quinineSQUIBB & SONS INC·Filed 1993·Granted Jan 25, 1994·24 cites·5 claims
- 1263US11033609B2Cyclic acetylcholinesterase C-terminal peptide in the treatment or prevention of cancer or metastasisNEURO BIO LTD·Filed 2019·Granted Jun 15, 2021·0 cites·2 claims
- 1361US2024369578A1Peptide t14 for braak stagingNEURO BIO LTD·Filed 2022·Application pending·0 cites
- 1458US5236932AMethod for treating Parkinson's disease employing quinineSQUIBB & SONS INC·Filed 1991·Granted Aug 17, 1993·25 cites·8 claims
- 1557US2024207373A1Cyclic peptides from the c-terminus of acetylcholinesterase for treatment of skin disorders and for cosmetical useNEURO BIO LTD·Filed 2021·Application pending·0 cites
- 1657US2024058424A1Nbp-14 for treating alzheimer's associated with down's syndromeNEURO BIO LTD·Filed 2021·Application pending·0 cites
- 1755US2025277798A1Skin biomarkerNEURO BIO LTD·Filed 2022·Application pending·0 cites
- 1851US2022361462A1Animal model for neurodegenerative disordersNEURO BIO LTD·Filed 2020·Application pending·0 cites
- 1945US11287416B2CancerNEURO BIO LTD·Filed 2017·Granted Mar 29, 2022·0 cites·15 claims
- 2039US2004038875A1Alpha 7nicotinic receptor screening assaysFiled 2001·Application pending·0 cites
- 2138US2020271673A1BiomarkerNEURO-BIO LTD·Filed 2018·Application pending·0 cites
- 2235US2012173975A1Control ring interface for computing systemsHERZ WILLIAM·Filed 2011·Application pending·0 cites
- 2335US2012173976A1Control panel and ring interface with a settings journal for computing systemsHERZ WILLIAM·Filed 2011·Application pending·0 cites
- 2434US2009226952A1Screening method for compounds with anaesthetic propertyISIS INNOVATION·Filed 2006·Application pending·0 cites
- 2532US11939398B2Modified peptides for use in treating neurodegenerative disordersNEURO BIO LTD·Filed 2017·Granted Mar 26, 2024·0 cites·7 claims
- 2631US2003051262A1Animal models for neurodegenerative diseaseFiled 2000·Application pending·0 cites
- 2721US7018839B2Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulatorSYNAPTICA LTD·Filed 1997·Granted Mar 28, 2006·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Susan Greenfield files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →